Drug Markets/Gemcitabine

Gemcitabine

3 NDCs across 2 manufacturers|3 Generic,0 Brand

Gemcitabine is used to treat breast neoplasms, non-small-cell lung carcinoma, pancreatic ductal carcinoma and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.

▸ More about this market

Gemcitabine is available as 3 NDCs from 2 manufacturers (3 generic, 0 brand), with NADAC prices from $20.00 to $20.00 per EA. Every pack size and labeler in this drug market is compared side-by-side below.

Total NDCs

3

3G / 0B

Manufacturers

2

competing in market

Price Spread

$20.00 – $20.00

per EA

7d Activity

3 flat

avg +0.0% WoW · of 3 NDCs

Market Price Trend

Monthly average NADAC per unit, split by generic and brand.

Explore this market from other angles

Move from the molecule page into the supplier, class, and trend views that create the strongest internal-link cluster for this market.

Manufacturer Breakdown

2 manufacturers producing GEMCITABINE

Drug Portfolio

3 NDCs total, 3 shown

Frequently Asked Questions

What is Gemcitabine used to treat?

Gemcitabine is used to treat breast neoplasms, non-small-cell lung carcinoma, pancreatic ductal carcinoma and ovarian neoplasms, per the National Library of Medicine's MED-RT classification.

How many Gemcitabine products are on the market?

The Gemcitabine drug market contains 3 NDCs from 2 manufacturers — 3 generic and 0 brand products.

What is the price range for Gemcitabine?

NADAC reference prices for Gemcitabine range from $19.9960 to $19.9960 per EA.

Which manufacturers make Gemcitabine?

2 manufacturers list Gemcitabine in NADAC. Ranked by number of NDCs, the largest are Fresenius Kabi USA, LLC (2), Hospira Inc. (1).